{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:33:47Z","timestamp":1792154027227,"version":"4.4.0"},"reference-count":93,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/qgts5711","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T05:02:17Z","timestamp":1743656537000},"page":"2322-2338","source":"Crossref","is-referenced-by-count":21,"title":["The calcium-sensing receptor: a comprehensive review on its role in calcium homeostasis and therapeutic implications"],"prefix":"10.62347","volume":"17","author":[{"given":"Ming","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"110173","DOI":"10.1016\/j.cbi.2022.110173","article-title":"Essential metals in health and disease","volume":"367","author":"Jomova","year":"2022","unstructured":"Jomova K, Makova M, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Rhodes CJ and Valko M. Essential metals in health and disease. Chem Biol Interact 2022; 367: 110173.","journal-title":"Chem Biol Interact"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ecl.2021.07.005","article-title":"Physiology of calcium homeostasis: an overview","volume":"50","author":"Matikainen","year":"2021","unstructured":"Matikainen N, Pekkarinen T, Ryhanen EM and Schalin-Jantti C. Physiology of calcium homeostasis: an overview. Endocrinol Metab Clin North Am 2021; 50: 575-590.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1137604","DOI":"10.3389\/fendo.2023.1137604","article-title":"Allosteric modulation of G protein-coupled receptor signaling","volume":"14","author":"Shen","year":"2023","unstructured":"Shen S, Zhao C, Wu C, Sun S, Li Z, Yan W and Shao Z. Allosteric modulation of G protein-coupled receptor signaling. Front Endocrinol (Lausanne) 2023; 14: 1137604.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-023-00156-w","article-title":"Structure, function and drug discovery of GPCR signaling","volume":"4","author":"Cheng","year":"2023","unstructured":"Cheng L, Xia F, Li Z, Shen C, Yang Z, Hou H, Sun S, Feng Y, Yong X, Tian X, Qin H, Yan W and Shao Z. Structure, function and drug discovery of GPCR signaling. Mol Biomed 2023; 4: 46.","journal-title":"Mol Biomed"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.37349\/etat.2022.00094","article-title":"Roles of calcium signaling in cancer metastasis to bone","volume":"3","author":"Xie","year":"2022","unstructured":"Xie T, Chen S, Hao J, Wu P, Gu X, Wei H, Li Z and Xiao J. Roles of calcium signaling in cancer metastasis to bone. Explor Target Antitumor Ther 2022; 3: 445-462.","journal-title":"Explor Target Antitumor Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/metabo12020111","article-title":"Molecular mechanisms of parathyroid disorders in chronic kidney disease","volume":"12","author":"Hassan","year":"2022","unstructured":"Hassan A, Khalaily N, Kilav-Levin R, Nechama M, Volovelsky O, Silver J and Naveh-Many T. Molecular mechanisms of parathyroid disorders in chronic kidney disease. Metabolites 2022; 12: 111.","journal-title":"Metabolites"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3390\/jcm11092595","article-title":"Disorders of the calcium sensing signaling pathway: from familial hypocalciuric hypercalcemia (FHH) to life threatening conditions in infancy","volume":"11","author":"H&#xF6","year":"2022","unstructured":"Höppner J, Sinningen K, Raimann A, Obermayer-Pietsch B and Grasemann C. Disorders of the calcium sensing signaling pathway: from familial hypocalciuric hypercalcemia (FHH) to life threatening conditions in infancy. J Clin Med 2022; 11: 2595.","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","article-title":"The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases","volume":"15","author":"Hannan","year":"2018","unstructured":"Hannan FM, Kallay E, Chang W, Brandi ML and Thakker RV. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat Rev Endocrinol 2018; 15: 33-51.","journal-title":"Nat Rev Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00223-015-0052-z","article-title":"Calcimimetic and calcilytic drugs: feats, flops, and futures","volume":"98","author":"Nemeth","year":"2016","unstructured":"Nemeth EF and Goodman WG. Calcimimetic and calcilytic drugs: feats, flops, and futures. Calcif Tissue Int 2016; 98: 341-358.","journal-title":"Calcif Tissue Int"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1111\/bph.14086","article-title":"Calcimimetic and calcilytic therapies for inherited disorders of the calcium-sensing receptor signalling pathway","volume":"175","author":"FM","year":"2018","unstructured":"Hannan FM, Olesen MK and Thakker RV. Calcimimetic and calcilytic therapies for inherited disorders of the calcium-sensing receptor signalling pathway. Br J Pharmacol 2018; 175: 4083-4094.","journal-title":"Br J Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Hannan FM, Babinsky VN and Thakker RV. Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis. J Mol Endocrinol 2016; 57: R127-142.","DOI":"10.1530\/JME-16-0124"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Yarova PL, Stewart AL, Sathish V, Britt RD Jr, Thompson MA, P Lowe AP, Freeman M, Aravamudan B, Kita H, Brennan SC, Schepelmann M, Davies T, Yung S, Cholisoh Z, Kidd EJ, Ford WR, Broadley KJ, Rietdorf K, Chang W, Bin Khayat ME, Ward DT, Corrigan CJ, T Ward JP, Kemp PJ, Pabelick CM, Prakash YS and Riccardi D. Calcium-sensing receptor antagonists abrogate airway hyperresponsiveness and inflammation in allergic asthma. Sci Transl Med 2015; 7: 284ra260.","DOI":"10.1126\/scitranslmed.aaa0282"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"20576","DOI":"10.1038\/s41598-021-00067-2","article-title":"Extracellular calcium alters calcium-sensing receptor network integrating intracellular calcium-signaling and related key pathway","volume":"11","author":"Gorkhali","year":"2021","unstructured":"Gorkhali R, Tian L, Dong B, Bagchi P, Deng X, Pawar S, Duong D, Fang N, Seyfried N and Yang J. Extracellular calcium alters calcium-sensing receptor network integrating intracellular calcium-signaling and related key pathway. Sci Rep 2021; 11: 20576.","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41586-024-07331-1","article-title":"Promiscuous G-protein activation by the calcium-sensing receptor","volume":"629","author":"Zuo","year":"2024","unstructured":"Zuo H, Park J, Frangaj A, Ye J, Lu G, Manning JJ, Asher WB, Lu Z, Hu GB, Wang L, Mendez J, Eng E, Zhang Z, Lin X, Grassucci R, Hendrickson WA, Clarke OB, Javitch JA, Conigrave AD and Fan QR. Promiscuous G-protein activation by the calcium-sensing receptor. Nature 2024; 629: 481-488.","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1530\/JME-21-0058","article-title":"Heterogeneity of G protein activation by the calcium-sensing receptor","volume":"67","author":"HA","year":"2021","unstructured":"Abid HA, Inoue A and Gorvin CM. Heterogeneity of G protein activation by the calcium-sensing receptor. J Mol Endocrinol 2021; 67: 41-53.","journal-title":"J Mol Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1359\/jbmr.1998.13.4.570","article-title":"Coupling of calcium receptors to inositol phosphate and cyclic AMP generation in mammalian cells and Xenopus laevis oocytes and immunodetection of receptor protein by region-specific antipeptide antisera","volume":"13","author":"Chang","year":"1998","unstructured":"Chang W, Pratt S, Chen TH, Nemeth E, Huang Z and Shoback D. Coupling of calcium receptors to inositol phosphate and cyclic AMP generation in mammalian cells and Xenopus laevis oocytes and immunodetection of receptor protein by region-specific antipeptide antisera. J Bone Miner Res 1998; 13: 570-580.","journal-title":"J Bone Miner Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.beem.2013.05.010","article-title":"Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways","volume":"27","author":"Conigrave","year":"2013","unstructured":"Conigrave AD and Ward DT. Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways. Best Pract Res Clin Endocrinol Metab 2013; 27: 315-331.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ceca.2011.11.009","article-title":"Biased agonism of the calcium-sensing receptor","volume":"51","author":"Thomsen","year":"2012","unstructured":"Thomsen AR, Hvidtfeldt M and Brauner-Osborne H. Biased agonism of the calcium-sensing receptor. Cell Calcium 2012; 51: 107-116.","journal-title":"Cell Calcium"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1210\/en.2002-220240","article-title":"Calcium-sensing receptor activation of rho involves filamin and rho-guanine nucleotide exchange factor","volume":"143","author":"Pi","year":"2002","unstructured":"Pi M, Spurney RF, Tu Q, Hinson T and Quarles LD. Calcium-sensing receptor activation of rho involves filamin and rho-guanine nucleotide exchange factor. Endocrinology 2002; 143: 3830-3838.","journal-title":"Endocrinology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"24435","DOI":"10.1074\/jbc.M801738200","article-title":"Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells","volume":"283","author":"Mamillapalli","year":"2008","unstructured":"Mamillapalli R, VanHouten J, Zawalich W and Wysolmerski J. Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells. J Biol Chem 2008; 283: 24435-24447.","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1677\/JOE-09-0183","article-title":"The calcium-sensing receptor couples to Galpha(s) and regulates PTHrP and ACTH secretion in pituitary cells","volume":"204","author":"Mamillapalli","year":"2010","unstructured":"Mamillapalli R and Wysolmerski J. The calcium-sensing receptor couples to Galpha(s) and regulates PTHrP and ACTH secretion in pituitary cells. J Endocrinol 2010; 204: 287-297.","journal-title":"J Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s42003-024-06189-3","article-title":"Absence of calcium-sensing receptor basal activity due to inter-subunit disulfide bridges","volume":"7","author":"Ma","year":"2024","unstructured":"Ma S, Yin X, Pin JP, Rondard P, Yi P and Liu J. Absence of calcium-sensing receptor basal activity due to inter-subunit disulfide bridges. Commun Biol 2024; 7: 501.","journal-title":"Commun Biol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3390\/cells11050914","article-title":"Into the tissues: extracellular matrix and its artificial substitutes: cell signalling mechanisms","volume":"11","author":"Bandzerewicz","year":"2022","unstructured":"Bandzerewicz A and Gadomska-Gajadhur A. Into the tissues: extracellular matrix and its artificial substitutes: cell signalling mechanisms. Cells 2022; 11: 914.","journal-title":"Cells"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1681\/ASN.2014070653","article-title":"Pathophysiologic changes in extracellular ph modulate parathyroid calcium-sensing receptor activity and secretion via a histidine-independent mechanism","volume":"26","author":"Campion","year":"2015","unstructured":"Campion KL, McCormick WD, Warwicker J, Khayat ME, Atkinson-Dell R, Steward MC, Delbridge LW, Mun HC, Conigrave AD and Ward DT. Pathophysiologic changes in extracellular ph modulate parathyroid calcium-sensing receptor activity and secretion via a histidine-independent mechanism. J Am Soc Nephrol 2015; 26: 2163-2171.","journal-title":"J Am Soc Nephrol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"19579","DOI":"10.1074\/jbc.273.31.19579","article-title":"Sodium and ionic strength sensing by the calcium receptor","volume":"273","author":"Quinn","year":"1998","unstructured":"Quinn SJ, Kifor O, Trivedi S, Diaz R, Vassilev P and Brown E. Sodium and ionic strength sensing by the calcium receptor. J Biol Chem 1998; 273: 19579-19586.","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","article-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism","volume":"67","author":"Colloton","year":"2005","unstructured":"Colloton M, Shatzen E, Miller G, Stehman-Breen C, Wada M, Lacey D and Martin D. Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism. Kidney Int 2005; 67: 467-476.","journal-title":"Kidney Int"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/1744-9987.12292","article-title":"Two years of cinacalcet hydrochloride treatment decreased parathyroid gland volume and serum parathyroid hormone level in hemodialysis patients with advanced secondary hyperparathyroidism","volume":"19","author":"Yamada","year":"2015","unstructured":"Yamada S, Tokumoto M, Taniguchi M, Toyonaga J, Suehiro T, Eriguchi R, Fujimi S, Ooboshi H, Kitazono T and Tsuruya K. Two years of cinacalcet hydrochloride treatment decreased parathyroid gland volume and serum parathyroid hormone level in hemodialysis patients with advanced secondary hyperparathyroidism. Ther Apher Dial 2015; 19: 367-377.","journal-title":"Ther Apher Dial"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Boisen IM, Du W, Juul A, Bräuner-Osborne H, Jensen AA and Blomberg Jensen M. Loss-of-function Thr347Ala variant in the G protein subunit-α11 causes familial hypocalciuric hypercalcemia 2 (FHH2). J Clin Endocrinol Metab 2024; dgae440.","DOI":"10.1210\/clinem\/dgae440"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/jbmr\/zjae199","article-title":"An activating CaSR variant with biased signaling reveals a critical residue for Gα11 coupling","volume":"40","author":"Benson","year":"2024","unstructured":"Benson MR, Wyatt RA, Levine MA and Gorvin CM. An activating CaSR variant with biased signaling reveals a critical residue for Gα11 coupling. J Bone Miner Res 2024; 40: 270-282.","journal-title":"J Bone Miner Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrneph.2016.59","article-title":"Localization and function of the renal calcium-sensing receptor","volume":"12","author":"Riccardi","year":"2016","unstructured":"Riccardi D and Valenti G. Localization and function of the renal calcium-sensing receptor. Nat Rev Nephrol 2016; 12: 414-425.","journal-title":"Nat Rev Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.coemr.2020.06.007","article-title":"Calcium-sensing receptor signaling - how human disease informs biology","volume":"16","author":"Gorvin","year":"2021","unstructured":"Gorvin CM. Calcium-sensing receptor signaling - how human disease informs biology. Curr Opin Endocr Metab Res 2021; 16: 10-28.","journal-title":"Curr Opin Endocr Metab Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrneph.2016.59","article-title":"Localization and function of the renal calcium-sensing receptor","volume":"12","author":"Riccardi","year":"2016","unstructured":"Riccardi D and Valenti G. Localization and function of the renal calcium-sensing receptor. Nature Reviews Nephrology 2016; 12: 414-425.","journal-title":"Nature Reviews Nephrology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1172\/JCI57407","article-title":"PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor","volume":"122","author":"Loupy","year":"2012","unstructured":"Loupy A, Ramakrishnan SK, Wootla B, Chambrey R, de la Faille R, Bourgeois S, Bruneval P, Mandet C, Christensen EI, Faure H, Cheval L, Laghmani K, Collet C, Eladari D, Dodd RH, Ruat M and Houillier P. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J Clin Invest 2012; 122: 3355-3367.","journal-title":"J Clin Invest"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcdb.2015.12.004","article-title":"Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism","volume":"49","author":"Santa Maria","year":"2016","unstructured":"Santa Maria C, Cheng Z, Li A, Wang J, Shoback D, Tu CL and Chang W. Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism. Semin Cell Dev Biol 2016; 49: 11-23.","journal-title":"Semin Cell Dev Biol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/jcb.25447","article-title":"Calcium sensing receptor function supports osteoblast survival and acts as a Co-factor in PTH anabolic actions in bone","volume":"117","author":"Al-Dujaili","year":"2016","unstructured":"Al-Dujaili SA, Koh AJ, Dang M, Mi X, Chang W, Ma PX and McCauley LK. Calcium sensing receptor function supports osteoblast survival and acts as a Co-factor in PTH anabolic actions in bone. J Cell Biochem 2016; 117: 1556-1567.","journal-title":"J Cell Biochem"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcdb.2015.12.004","article-title":"Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism","volume":"49","author":"Santa Maria","year":"2016","unstructured":"Santa Maria C, Cheng Z, Li A, Wang J, Shoback D, Tu CL and Chang W. Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism. Semin Cell Dev Biol 2016; 49: 11-23.","journal-title":"Semin Cell Dev Biol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrendo.2015.30","article-title":"The calcium-sensing receptor in bone--mechanistic and therapeutic insights","volume":"11","author":"Goltzman","year":"2015","unstructured":"Goltzman D and Hendy GN. The calcium-sensing receptor in bone--mechanistic and therapeutic insights. Nat Rev Endocrinol 2015; 11: 298-307.","journal-title":"Nat Rev Endocrinol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1111\/bph.14344","article-title":"Divergent effects of strontium and calcium-sensing receptor positive allosteric modulators (calcimimetics) on human osteoclast activity","volume":"175","author":"Diepenhorst","year":"2018","unstructured":"Diepenhorst NA, Leach K, Keller AN, Rueda P, Cook AE, Pierce TL, Nowell C, Pastoureau P, Sabatini M, Summers RJ, Charman WN, Sexton PM, Christopoulos A and Langmead CJ. Divergent effects of strontium and calcium-sensing receptor positive allosteric modulators (calcimimetics) on human osteoclast activity. Br J Pharmacol 2018; 175: 4095-4108.","journal-title":"Br J Pharmacol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/j.1476-5381.2009.00305.x","article-title":"Osteoblasts play key roles in the mechanisms of action of strontium ranelate","volume":"157","author":"Brennan","year":"2009","unstructured":"Brennan TC, Rybchyn MS, Green W, Atwa S, Conigrave AD and Mason RS. Osteoblasts play key roles in the mechanisms of action of strontium ranelate. Br J Pharmacol 2009; 157: 1291-1300.","journal-title":"Br J Pharmacol"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"He Y, Jiang H and Dong S. Bioactives and biomaterial construction for modulating osteoclast activities. Adv Healthc Mater 2024; 13: e2302807.","DOI":"10.1002\/adhm.202302807"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1172\/JCI200418776","article-title":"The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport","volume":"113","author":"VanHouten","year":"2004","unstructured":"VanHouten J, Dann P, McGeoch G, Brown EM, Krapcho K, Neville M and Wysolmerski JJ. The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport. J Clin Invest 2004; 113: 598-608.","journal-title":"J Clin Invest"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fphys.2016.00440","article-title":"Calcium-sensing receptor in breast physiology and cancer","volume":"7","author":"Kim","year":"2016","unstructured":"Kim W and Wysolmerski JJ. Calcium-sensing receptor in breast physiology and cancer. Front Physiol 2016; 7: 440.","journal-title":"Front Physiol"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Zhang C, Zhang T, Zou J, Miller CL, Gorkhali R, Yang JY, Schilmiller A, Wang S, Huang K, Brown EM, Moremen KW, Hu J and Yang JJ. Structural basis for regulation of human calcium-sensing receptor by magnesium ions and an unexpected tryptophan derivative co-agonist. Sci Adv 2016; 2: e1600241.","DOI":"10.1126\/sciadv.1600241"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Geng Y, Mosyak L, Kurinov I, Zuo H, Sturchler E, Cheng TC, Subramanyam P, Brown AP, Brennan SC, Mun HC, Bush M, Chen Y, Nguyen TX, Cao B, Chang DD, Quick M, Conigrave AD, Colecraft HM, McDonald P and Fan QR. Structural mechanism of ligand activation in human calcium-sensing receptor. Elife 2016; 5: e13662.","DOI":"10.7554\/eLife.13662"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41422-021-00474-0","article-title":"Structural mechanism of cooperative activation of the human calcium-sensing receptor by Ca(2+) ions and L-tryptophan","volume":"31","author":"Ling","year":"2021","unstructured":"Ling S, Shi P, Liu S, Meng X, Zhou Y, Sun W, Chang S, Zhang X, Zhang L, Shi C, Sun D, Liu L and Tian C. Structural mechanism of cooperative activation of the human calcium-sensing receptor by Ca(2+) ions and L-tryptophan. Cell Res 2021; 31: 383-394.","journal-title":"Cell Res"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Chen X, Wang L, Cui Q, Ding Z, Han L, Kou Y, Zhang W, Wang H, Jia X, Dai M, Shi Z, Li Y, Li X and Geng Y. Structural insights into the activation of human calcium-sensing receptor. Elife 2021; 10: e68578.","DOI":"10.7554\/eLife.68578"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41586-021-03691-0","article-title":"Asymmetric activation of the calcium-sensing receptor homodimer","volume":"595","author":"Gao","year":"2021","unstructured":"Gao Y, Robertson MJ, Rahman SN, Seven AB, Zhang C, Meyerowitz JG, Panova O, Hannan FM, Thakker RV, Bräuner-Osborne H, Mathiesen JM and Skiniotis G. Asymmetric activation of the calcium-sensing receptor homodimer. Nature 2021; 595: 455-459.","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Park J, Zuo H, Frangaj A, Fu Z, Yen LY, Zhang Z, Mosyak L, Slavkovich VN, Liu J, Ray KM, Cao B, Vallese F, Geng Y, Chen S, Grassucci R, Dandey VP, Tan YZ, Eng E, Lee Y, Kloss B, Liu Z, Hendrickson WA, Potter CS, Carragher B, Graziano J, Conigrave AD, Frank J, Clarke OB and Fan QR. Symmetric activation and modulation of the human calcium-sensing receptor. Proc Natl Acad Sci U S A 2021; 118: e2115849118.","DOI":"10.1073\/pnas.2115849118"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Wen T, Wang Z, Chen X, Ren Y, Lu X, Xing Y, Lu J, Chang S, Zhang X, Shen Y and Yang X. Structural basis for activation and allosteric modulation of full-length calcium-sensing receptor. Sci Adv 2021; 7: eabg1483.","DOI":"10.1126\/sciadv.abg1483"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41422-023-00892-2","article-title":"Structural insights into asymmetric activation of the calcium-sensing receptor-G(q) complex","volume":"34","author":"Ling","year":"2024","unstructured":"Ling S, Meng X, Zhang Y, Xia Z, Zhou Y, Yang F, Shi P, Shi C and Tian C. Structural insights into asymmetric activation of the calcium-sensing receptor-G(q) complex. Cell Res 2024; 34: 169-172.","journal-title":"Cell Res"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"21711","DOI":"10.1073\/pnas.1922231117","article-title":"Illuminating the allosteric modulation of the calcium-sensing receptor","volume":"117","author":"Liu","year":"2020","unstructured":"Liu H, Yi P, Zhao W, Wu Y, Acher F, Pin JP, Liu J and Rondard P. Illuminating the allosteric modulation of the calcium-sensing receptor. Proc Natl Acad Sci U S A 2020; 117: 21711-21722.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmch.2017.12.001","article-title":"Discovery and development of calcimimetic and calcilytic compounds","volume":"57","author":"EF","year":"2018","unstructured":"Nemeth EF, Van Wagenen BC and Balandrin MF. Discovery and development of calcimimetic and calcilytic compounds. Prog Med Chem 2018; 57: 1-86.","journal-title":"Prog Med Chem"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Liu F, Wu CG, Tu CL, Glenn I, Meyerowitz J, Kaplan AL, Lyu J, Cheng Z, Tarkhanova OO, Moroz YS, Irwin JJ, Chang W, Shoichet BK and Skiniotis G. Large library docking identifies positive allosteric modulators of the calcium-sensing receptor. Science 2024; 385: eado1868.","DOI":"10.1126\/science.ado1868"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41586-024-07055-2","article-title":"Allosteric modulation and G-protein selectivity of the Ca(2+)-sensing receptor","volume":"626","author":"He","year":"2024","unstructured":"He F, Wu CG, Gao Y, Rahman SN, Zaoralová M, Papasergi-Scott MM, Gu TJ, Robertson MJ, Seven AB, Li L, Mathiesen JM and Skiniotis G. Allosteric modulation and G-protein selectivity of the Ca(2+)-sensing receptor. Nature 2024; 626: 1141-1148.","journal-title":"Nature"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41422-020-0350-5","article-title":"Cryo-EM structures of inactive and active GABA(B) receptor","volume":"30","author":"Mao","year":"2020","unstructured":"Mao C, Shen C, Li C, Shen DD, Xu C, Zhang S, Zhou R, Shen Q, Chen LN, Jiang Z, Liu J and Zhang Y. Cryo-EM structures of inactive and active GABA(B) receptor. Cell Res 2020; 30: 564-573.","journal-title":"Cell Res"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1021\/acsptsci.8b00021","article-title":"Dual action calcium-sensing receptor modulator unmasks novel mode-switching mechanism","volume":"1","author":"Gregory","year":"2018","unstructured":"Gregory KJ, Kufareva I, Keller AN, Khajehali E, Mun HC, Goolam MA, Mason RS, Capuano B, Conigrave AD, Christopoulos A and Leach K. Dual action calcium-sensing receptor modulator unmasks novel mode-switching mechanism. ACS Pharmacol Transl Sci 2018; 1: 96-109.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"46355","DOI":"10.1038\/srep46355","article-title":"Investigating the molecular mechanism of positive and negative allosteric modulators in the calcium-sensing receptor dimer","volume":"7","author":"Jacobsen","year":"2017","unstructured":"Jacobsen SE, Gether U and Brauner-Osborne H. Investigating the molecular mechanism of positive and negative allosteric modulators in the calcium-sensing receptor dimer. Sci Rep 2017; 7: 46355.","journal-title":"Sci Rep"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"149401","DOI":"10.1016\/j.bbrc.2023.149401","article-title":"Nanobodies as negative allosteric modulators for human calcium sensing receptor","volume":"695","author":"Cui","year":"2024","unstructured":"Cui Q, Wang L, Wang H, Chen X, Han L, Geng T, Kou Y, Zhang W, Dai M, Qiao H, Sun Z, Li L, Lan Z, Xu H, Xu J, Dai Y and Geng Y. Nanobodies as negative allosteric modulators for human calcium sensing receptor. Biochem Biophys Res Commun 2024; 695: 149401.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","unstructured":"Cunningham J, Locatelli F and Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 2011; 6: 913-921.","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"490","DOI":"10.5603\/ep.95820","article-title":"Secondary hyperparathyroidism in chronic kidney disease: pathomechanism and current treatment possibilities","volume":"74","author":"Rodzo&#x144","year":"2023","unstructured":"Rodzoń-Norwicz M, Norwicz S, Sowa-Kućma M and Gala-Błądzińska A. Secondary hyperparathyroidism in chronic kidney disease: pathomechanism and current treatment possibilities. Endokrynol Pol 2023; 74: 490-498.","journal-title":"Endokrynol Pol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.kint.2018.05.013","article-title":"Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"94","author":"Fukagawa","year":"2018","unstructured":"Fukagawa M, Shimazaki R and Akizawa T; Evocalcet study group. Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 2018; 94: 818-825.","journal-title":"Kidney Int"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Palmer SC, Nistor I, Craig JC, Pellegrini F, Messa P, Tonelli M, Covic A and Strippoli GF. Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med 2013; 10: e1001436.","DOI":"10.1371\/journal.pmed.1001436"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11154-021-09694-6","article-title":"The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies","volume":"23","author":"Chandran","year":"2022","unstructured":"Chandran M, Bilezikian JP, Lau J, Rajeev R, Yang SP, Samuel M and Parameswaran R. The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies. Rev Endocr Metab Disord 2022; 23: 485-501.","journal-title":"Rev Endocr Metab Disord"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00268-022-06439-7","article-title":"Parathyroidectomy versus cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients","volume":"46","author":"Alvarado","year":"2022","unstructured":"Alvarado L, Sharma N, Lerma R, Dwivedi A, Ahmad A, Hechanova A, Payan-Schober F, Nwosu A and Alkhalili E. Parathyroidectomy versus cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients. World J Surg 2022; 46: 813-819.","journal-title":"World J Surg"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s11255-023-03844-2","article-title":"Safety of cinacalcet in children and adolescents with chronic kidney disease-mineral bone disorder: systematic review and proportional meta-analysis of case series","volume":"56","author":"Zamoner","year":"2024","unstructured":"Zamoner SMS, Takase HM, Riyuzo MC, Caramori JCT and de Andrade LGM. Safety of cinacalcet in children and adolescents with chronic kidney disease-mineral bone disorder: systematic review and proportional meta-analysis of case series. Int Urol Nephrol 2024; 56: 1669-1676.","journal-title":"Int Urol Nephrol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13318-022-00775-8","article-title":"Physiologically-based pharmacokinetic models of CYP2D6 substrate and inhibitors nebivolol, cinacalcet and mirabegron to simulate drug-drug interactions","volume":"47","author":"Kilford","year":"2022","unstructured":"Kilford P, Khoshaein N, Southall R and Gardner I. Physiologically-based pharmacokinetic models of CYP2D6 substrate and inhibitors nebivolol, cinacalcet and mirabegron to simulate drug-drug interactions. Eur J Drug Metab Pharmacokinet 2022; 47: 699-710.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1021\/acsptsci.1c00046","article-title":"Therapeutic opportunities of targeting allosteric binding sites on the calcium-sensing receptor","volume":"4","author":"Diao","year":"2021","unstructured":"Diao J, DeBono A, Josephs TM, Bourke JE, Capuano B, Gregory KJ and Leach K. Therapeutic opportunities of targeting allosteric binding sites on the calcium-sensing receptor. ACS Pharmacol Transl Sci 2021; 4: 666-679.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3390\/jcm8071066","article-title":"multicenter study in “real life”","volume":"8","author":"Russo","year":"2019","unstructured":"Russo D, Tripepi R, Malberti F, Di Iorio B, Scognamiglio B, Di Lullo L, Paduano IG, Tripepi GL and Panuccio VA. Etelcalcetide in patients on hemodialysis with severe secondary hyperparathyroidism. multicenter study in “real life”. J Clin Med 2019; 8: 1066.","journal-title":"J Clin Med"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s11739-021-02671-6","article-title":"Hypocalcemia is associated with adverse clinical course in patients with upper gastrointestinal bleeding","volume":"16","author":"Korytny","year":"2021","unstructured":"Korytny A, Klein A, Marcusohn E, Freund Y, Neuberger A, Raz A, Miller A and Epstein D. Hypocalcemia is associated with adverse clinical course in patients with upper gastrointestinal bleeding. Intern Emerg Med 2021; 16: 1813-1822.","journal-title":"Intern Emerg Med"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Kawata T, Tokunaga S, Murai M, Masuda N, Haruyama W, Shoukei Y, Hisada Y, Yanagida T, Miyazaki H, Wada M, Akizawa T and Fukagawa M. A novel calcimimetic agent, evocalcet (MT-4580\/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro. PLoS One 2018; 13: e0195316.","DOI":"10.1371\/journal.pone.0195316"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s40265-021-01578-y","article-title":"Upacicalcet: first approval","volume":"81","author":"Hoy","year":"2021","unstructured":"Hoy SM. Upacicalcet: first approval. Drugs 2021; 81: 1593-1596.","journal-title":"Drugs"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40268-022-00385-4","article-title":"First-in-human phase I study of the novel injectable calcimimetic agent upacicalcet in healthy adult Japanese participants","volume":"22","author":"Koiwa","year":"2022","unstructured":"Koiwa F, Yazawa R, Fukagawa M, Honda D and Akizawa T. First-in-human phase I study of the novel injectable calcimimetic agent upacicalcet in healthy adult Japanese participants. Drugs R D 2022; 22: 131-140.","journal-title":"Drugs R D"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.beem.2014.09.003","article-title":"Efficacy and safety of currently marketed anti-osteoporosis medications","volume":"28","author":"Reginster","year":"2014","unstructured":"Reginster JY, Neuprez A, Dardenne N, Beaudart C, Emonts P and Bruyere O. Efficacy and safety of currently marketed anti-osteoporosis medications. Best Pract Res Clin Endocrinol Metab 2014; 28: 809-834.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1759720X13483187","article-title":"A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis","volume":"5","author":"Cianferotti","year":"2013","unstructured":"Cianferotti L, D’Asta F and Brandi ML. A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis 2013; 5: 127-139.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Marie PJ. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation. Curr Opin Rheumatol 2006; 18 Suppl 1: S11-15.","DOI":"10.1097\/01.bor.0000229522.89546.7b"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00223-011-9499-8","article-title":"Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis","volume":"89","author":"Rizzoli","year":"2011","unstructured":"Rizzoli R, Reginster JY, Boonen S, Breart G, Diez-Perez A, Felsenberg D, Kaufman JM, Kanis JA and Cooper C. Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int 2011; 89: 91-104.","journal-title":"Calcif Tissue Int"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00198-009-1097-5","article-title":"Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity","volume":"21","author":"Musette","year":"2010","unstructured":"Musette P, Brandi ML, Cacoub P, Kaufman JM, Rizzoli R and Reginster JY. Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity. Osteoporos Int 2010; 21: 723-732.","journal-title":"Osteoporos Int"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/jbmr.3824","article-title":"Design and preclinical development of transcon PTH, an investigational sustained-release PTH replacement therapy for hypoparathyroidism","volume":"34","author":"Holten-Andersen","year":"2019","unstructured":"Holten-Andersen L, Pihl S, Rasmussen CE, Zettler J, Maitro G, Baron J, Heinig S, Hoffmann E, Wegge T, Krusch M, Faltinger F, Killian S, Sprogoe K, Karpf DB, Breinholt VM and Cleemann F. Design and preclinical development of transcon PTH, an investigational sustained-release PTH replacement therapy for hypoparathyroidism. J Bone Miner Res 2019; 34: 2075-2086.","journal-title":"J Bone Miner Res"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/jbmr.4016","article-title":"A randomized double-blind placebo-controlled first-in-human phase 1 trial of transcon pth in healthy adults","volume":"35","author":"Karpf","year":"2020","unstructured":"Karpf DB, Pihl S, Mourya S, Mortensen E, Kovoor E, Markova D and Leff JA. A randomized double-blind placebo-controlled first-in-human phase 1 trial of transcon pth in healthy adults. J Bone Miner Res 2020; 35: 1430-1440.","journal-title":"J Bone Miner Res"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.beem.2014.09.001","article-title":"Parathyroid hormone therapy for hypoparathyroidism","volume":"29","author":"NE","year":"2015","unstructured":"Cusano NE, Rubin MR and Bilezikian JP. Parathyroid hormone therapy for hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 2015; 29: 47-55.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"JP","year":"2011","unstructured":"Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, Juppner H, D’Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J and Sanders J. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 2011; 26: 2317-2337.","journal-title":"J Bone Miner Res"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Pees A, Beaino W, Kooijman EJM, Schreurs M, Verlaan M, Schuit RC, Vosjan M, Engelsman AF, Windhorst AD and Vugts DJ. Synthesis and evaluation of [(18)F]cinacalcet for the imaging of parathyroid hyperplasia. Nucl Med Biol 2021; 102-103: 97-105.","DOI":"10.1016\/j.nucmedbio.2021.10.003"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Sato T, Verma S, Khatri A, Dean T, Goransson O, Gardella TJ and Wein MN. Comparable initial engagement of intracellular signaling pathways by parathyroid hormone receptor ligands teriparatide, abaloparatide, and long-acting PTH. JBMR Plus 2021; 5: e10441.","DOI":"10.1002\/jbm4.10441"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.3390\/nu11123072","article-title":"Nutritional and pharmacological targeting of the calcium-sensing receptor influences chemically induced colitis in mice","volume":"11","author":"Elajnaf","year":"2019","unstructured":"Elajnaf T, Iamartino L, Mesteri I, Muller C, Bassetto M, Manhardt T, Baumgartner-Parzer S, Kallay E and Schepelmann M. Nutritional and pharmacological targeting of the calcium-sensing receptor influences chemically induced colitis in mice. Nutrients 2019; 11: 3072.","journal-title":"Nutrients"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1016\/j.bmcl.2017.09.008","article-title":"Identification of potent, nonabsorbable agonists of the calcium-sensing receptor for GI-specific administration","volume":"27","author":"Sparks","year":"2017","unstructured":"Sparks SM, Spearing PK, Diaz CJ, Cowan DJ, Jayawickreme C, Chen G, Rimele TJ, Generaux C, Harston LT and Roller SG. Identification of potent, nonabsorbable agonists of the calcium-sensing receptor for GI-specific administration. Bioorg Med Chem Lett 2017; 27: 4673-4677.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.dmpk.2018.03.001","article-title":"A phase I, open-label, single-dose micro tracer mass balance study of (14)C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry","volume":"33","author":"Miyatake","year":"2018","unstructured":"Miyatake D, Nakada N, Takada A, Kato K, Taniuchi Y, Katashima M and Sawamoto T. A phase I, open-label, single-dose micro tracer mass balance study of (14)C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry. Drug Metab Pharmacokinet 2018; 33: 118-124.","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/13543784.2024.2369307","article-title":"Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs","volume":"33","author":"Magagnoli","year":"2024","unstructured":"Magagnoli L, Ciceri P and Cozzolino M. Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs. Expert Opin Investig Drugs 2024; 33: 775-789.","journal-title":"Expert Opin Investig Drugs"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jid.2018.09.033","article-title":"Calcium-sensing receptor regulates epidermal intracellular Ca(2+) signaling and re-epithelialization after wounding","volume":"139","author":"CL","year":"2019","unstructured":"Tu CL, Celli A, Mauro T and Chang W. Calcium-sensing receptor regulates epidermal intracellular Ca(2+) signaling and re-epithelialization after wounding. J Invest Dermatol 2019; 139: 919-929.","journal-title":"J Invest Dermatol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1002\/cmdc.202000840","article-title":"Trends in drug discovery over five decades - the european federation for medicinal chemistry international symposium on medicinal chemistry (EFMC-ISMC)","volume":"15","author":"Differding","year":"2020","unstructured":"Differding E. Trends in drug discovery over five decades - the european federation for medicinal chemistry international symposium on medicinal chemistry (EFMC-ISMC). ChemMedChem 2020; 15: 2352-2358.","journal-title":"ChemMedChem"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrendo.2011.212","article-title":"Bone: ronacaleret in osteoporosis","volume":"8","author":"Diaz","year":"2011","unstructured":"Diaz R. Bone: ronacaleret in osteoporosis. Nat Rev Endocrinol 2011; 8: 67.","journal-title":"Nat Rev Endocrinol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"190095","DOI":"10.1183\/16000617.0095-2019","article-title":"The future of bronchodilation: looking for new classes of bronchodilators","volume":"28","author":"Cazzola","year":"2019","unstructured":"Cazzola M, Rogliani P and Matera MG. The future of bronchodilation: looking for new classes of bronchodilators. Eur Respir Rev 2019; 28: 190095.","journal-title":"Eur Respir Rev"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bone.2009.09.028","article-title":"An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation","volume":"46","author":"Kumar","year":"2010","unstructured":"Kumar S, Matheny CJ, Hoffman SJ, Marquis RW, Schultz M, Liang X, Vasko JA, Stroup GB, Vaden VR, Haley H, Fox J, DelMar EG, Nemeth EF, Lago AM, Callahan JF, Bhatnagar P, Huffman WF, Gowen M, Yi B, Danoff TM and Fitzpatrick LA. An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation. Bone 2010; 46: 534-542.","journal-title":"Bone"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1210\/jc.85.9.3069","article-title":"Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers","volume":"85","author":"Kurland","year":"2000","unstructured":"Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R and Bilezikian JP. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab 2000; 85: 3069-3076.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/3\/ajtr0163120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:51:07Z","timestamp":1766022667000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/3\/ajtr0163120.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":93,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/qgts5711","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}